Skip to Content

Hyaluronidase

In the US, Hyaluronidase (hyaluronidase systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Extravasation, Hypodermoclysis and Subcutaneous Urography.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B06AA03

CAS registry number (Chemical Abstracts Service)

0009001-54-1

Therapeutic Category

Enzyme

Chemical Names

Enzymes of various origins which depolymerize hyaluronic acid.

Hyaluronidase

Foreign Names

  • Hyaluronidasum (Latin)
  • Hyaluronidase (German)
  • Hyaluronidase (French)
  • Hialuronidasa (Spanish)

Generic Names

Brand Names

  • Amphadase
    Amphastar, United States
  • Bilidazum
    Biopharm, Georgia
  • Helason (Hyaluronidase and Heparin)
    PharmaSwiss, Poland
  • Hyalase
    Artex, New Zealand; CP Pharmaceuticals, Israel; Wockhardt, Egypt; Wockhardt, Lebanon; Wockhardt, Malta; Wockhardt UK, United Kingdom; Xixia, South Africa
  • Hyalozima
    Apsen, Brazil
  • Hyason
    Riemser, Netherlands
  • Hyasone
    Eureco-Pharma, Netherlands; Riemser, Netherlands
  • Hylase
    CP Pharm, Oman; Riemser, Czech Republic
  • Hylase Dessau
    Jaytech Biogen, South Korea; Kemofarmacija, Slovenia; Riemser Pharma, Austria; Riemser Pharma, Germany
  • Hylenex
    Halozyme, United States
  • Lydasum-Biopharma
    Biopharma, Georgia
  • Postec (Hyaluronidase and Betamethasone)
    Apsen, Brazil
  • Vitrase
    Bausch & Lomb, United States
  • Wockhardt Hyalase
    Wockhardt UK Ltd, Hong Kong

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide